The potential role of fecal carbonic anhydrase II in screening for colorectal cancer

American Surgeon

Volumn 63, Issue 3, 1997, Pages 243-246

  Yokoyama, Sachio ^a   Shatney, Clayton H ^b   Mochizuki, Hidetaka ^a   Hase, Kazuo ^a   Johnson, Denise L ^c   Cummings, Susan ^b   Trollope, Michael L ^d   Tamakuma, Shoetsu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE;

ADULT; ARTICLE; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES LEVEL; FEMALE; HUMAN; IMMUNOCHEMISTRY; MALE; OCCULT BLOOD;

CARBONIC ANHYDRASES; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030944522     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Simon JB. Occult blood screening for colorectal carcinoma: A critical review. Gastroenterology 1985;88:820-37.
2. Frommer DJ, Kapparis A, Brown MK. Improved screening for colorectal cancer by immunological detection of occult blood. Br Med J, 1988;296:1092-4.
3. Northover JMA, Kettner JD. Bowel Cancer. New York: Oxford University Press, 1992, pp 37-68.
4. Reilly JM, Ballantyne GH, Fleming FX, et al. Evaluation of the occult blood test in screening for colorectal neoplasms: A prospective study using flexible endoscopy. Am Surg 1990;56:119-123.
5. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. JAMA 1994;271:1011-3.
6. Gramlich TL, Hennigar RA, Spicer SS, Schulte BA. Immunohistochemical localization of sodium-potassium-stimulated adenosine triphosphatase and carbonic anhydrase in human colon and colonic neoplasms. Arch Pathol Lab Med 1990;114:415-9.
7. Mori M, Staniunas RJ, Barnard GF, et al. The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 1993;105:820-6.
8. Yokoyama S, Mochizuki H, Bekku S, Tamakuma S. Significance of carbonic anhydrase II in rat colonie carcinogenesis. J Natl Def Med Coll 1994;18:341-2.
9. Dubrow R, Yannielli L. Fecal protein markers of colorectal cancer. Am J Gastroenterol 1992;87:854-8.
10. Lieberman D. Screening/early detection model for colorectal cancer. Cancer 1994;74:2023-7.
11. Williams NS. Colorectal cancer: Epidemiology, aetiology, pathology, clinical features and diagnosis. In: Keighley MRB, Williams NS, eds. Surgery of the Anus, Rectum and Colon. London: W.B. Saunders, 1993, pp 924-31.
12. Sontag SJ, Durczak C, Aranha GV, et al. Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. Am J Surg 1983;145:89-94.
13. Green FL. Distribution of colorecal neoplasms: A left to right shift of polyps and cancer. Am Surg 1983;49:62-5.
14. Tashian RE. The carbonic anhydrases: Widening perspectives on their evolution, expression and function. Bioassays 1989; 10:186-92.
15. Hewett-Emmett D, Hopkins PJ, Tashian RE. Origins and molecular evolution of the carbonic anhydrase ioszymes. Ann NY Acad Sci 1984;429:338-58.
16. Lonnerholm G, Selking O, Wistrand PJ. Amount and distribution of carbonic anhydrases CA I and CA II in the gastrointestinal tract. Gastroenterology 1985;88:1151-61.
17. Sadahiro S. A study of tumor-associated cellular proteins from carcinoma and adenoma of the human colon. Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 1987;88:551-61.
18. Pretlow TP, Roukhadze EV, O'Riordan MA, et al. Carcinoembryonic antigen in human colonic aberrant crypt foci. Gastroenterology, 1994;107:1719-25.
19. Pretlow TP, O'Riordan MA, Kolman MF, Jurcisek JA. Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity. Am J Pathol 1990;136:13-6.
20. Yokoyama S, Mochizuki H, Hase K, et al. Immunohistochemical study of carbonic anhydrase and cell proliferative activity in colorectal cancer and normal mucosa. J Jpn Soc Coloproctol 1992;45:665.
21. Parkes JL, Coleman PS. Enhancement of carbonic anhydrase activity by erythrocyte membranes. Arch Biochem Biophys 1989;275:459-68.
22. Carter ND, Heath R, Welty RJ, et al. Red cells genetically deficient in carbonic anhydrase II have elevated levels of carbonic anhydrase indistinguishable from muscle CA III. Ann NY Acad Sci 1984;429:284-6.
23. Alpern RJ, Stone DK, Rector FC Jr. Renal acidification mechanisms. In: Brenner BM, Rector FC, eds. The Kidney. Philadelphia: W.B. Saunders, 1991, pp 353-9.